Topics range from the exploration of extraterrestrial life to the paper applications of the future / Approximately €170 million in funding for the first funding period

In early 2026, the EU extended its domestic carbon pricing to key products from beyond its borders. This is managed through the “Carbon Border Adjustment Mechanism” (CBAM). Exporters of polluting goods to the EU must pay a climate tariff, unless their country has its own pricing scheme. A study finds that this could incentivise EU trade partners to adopt carbon pricing as well. In particular Canada, Japan, Taiwan and South Korea are found to be likely candidates, leading to 73 percent more CO₂ emissions being avoided compared to when only the EU applies its climate policy.

About The Study: This scoping review provides a detailed comparison of biosimilar regulatory guidelines across all World Health Organization regions and identified similarities and differences that may limit the transferability of data between and among countries. These barriers can potentially affect medication availability, price, access, and reimbursement of biosimilars.

Researchers at the University of British Columbia found that B.C.’s decision to provide universal, no-cost prescription contraception sharply reduced what patients pay, with the largest financial gains for people in their 20s. Before the policy, the pill averaged about $25 per month, while IUDs ranged from $75 to more than $500 up front—and for long-term pill users, lifetime costs could reach $10,000. Two years after the policy change, patient spending was 83 per cent lower than expected, translating to average savings of $43 per contraceptive user per year.